相关实验视频
Updated: Sep 10, 2025
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
在多重聚变阳性瘤中,seclidemstat (SP-2577) 诱导转录基因重编程和细胞毒性
Galen C Rask1, Cenny Taslim2, Ariunaa Bayanjargal3
1Nationwide Children's Hospital, Columbus, OH, United States.
Cancer research communications
|August 25, 2025
概括
通过逆转瘤转录,Seclidemstat对各种聚变阳性瘤具有强大的抗癌活性. 这表明seclidemstat对于这些恶性瘤是一种有前途的治疗策略.
科学领域:
- 癌症学
- 分子生物学
- 遗传学
背景情况:
- 编码FET蛋白的基因 (FUS,EWSR1,TAF15) 通过融合瘤蛋白驱动罕见的侵袭性瘤.
- 难以直接向致癌转录因子 (TF),因此需要新的治疗策略.
- 塞克利德姆斯塔特 (SP-2577) 是用于FET重组瘤的临床试验中的小分子,但其活性需要证明.
研究的目的:
- 评估seclidemstat在各种FET重组和融合阳性肉瘤细胞系中的药理活性和细胞毒性.
- 使用大量RNA测序来定义seclidemstat治疗的转录效应.
- 评估seclidemstat作为新型治疗瘤的潜力.
主要方法:
- 在多个肉瘤细胞系上进行体外细胞毒性测定.
- 在seclidemstat治疗后进行大量RNA测序以分析转录组变化.
- 在Ewing肉瘤中,seclidemstat与SP-2509的转录效应的比较.
主要成果:
- 塞克利德姆斯塔特对FET重组和其他融合阳性肉瘤细胞系表现出强烈的细胞毒性.
- 转录组分析显示,在所有测试细胞系中,seclidemstat诱导的转录变化广泛存在.
- 在Ewing肉瘤中,Seclidemstat逆转了FET融合转录特征,包括EWSR1:: WT1,EWSR1:: ATF1和EWSR1:: ERG,并回顾了SP-2509的活性.
结论:
- 在各种融合阳性瘤中,Seclidemstat具有显著的抗癌活性,并逆转瘤转录程序.
- 尽管单剂疗效存在挑战,但seclidemstat对于FET重组和其他融合驱动的瘤患者来说是一个有前途的治疗策略.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.1K
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
7.3K
相关概念视频
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K